IndiaTickerVista Pharmaceuticals Ltd - 524711 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Vista Pharmaceuticals
BSE:VISTAPH · ISIN INE427C01021
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Vista Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Vista Pharmaceuticals Ltd - 524711 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2026BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2BSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Results For The Quarter Ended 31.12.2025BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Board Meeting Outcome for Un Audited Financial Results For The Quarter Ended 31.12.2025BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Update on board meetingBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025.
2. Limited Review Report Quarter And Nine Months 31.12.2025.
3. Any Other Business With The Permission Of The Chair.BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - 'Joint Venture Partnership Between Pleiades Therapeutics And Vista Pharmaceuticals Ltd'BSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Un Audited Financials Results For The Quarter And Half Year Ended 30.09.2025BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Board Meeting Outcome for Un Audited Financial Results For The Quarter And Half Year Ended 30.09.2025BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter Ended 30.09.2025.
2. Limited Review Report For Quarter Ended 30.09.2025.
3. Any Other Business With The Permission Of The Chair.BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Intimation Of Book Closure Regarding 34" Annual General MeetingBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - 34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, 30Th September 2025BSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended 30.06.2025BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Re-Appointment Of Mr. Dhananjaya Alli (DIN: 00610909) As An Whole Time Director Of The CompanyBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The CompanyBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Results - Unaudited Financial Results For The Quarter Ended 30.06.2025BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing Director Of The CompanyBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2025BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Outcome Of Circular Resolution Passed By Board Of Directors Of The Company By Circulation On July 16, 2025 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2025BSE · financial results · pdf
Source filing Vista Pharmaceuticals Ltd - 524711 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2BSE · exchange filing · pdf
Source filing